These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 22356309

  • 1. Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells.
    Wang JH, DU JP, Li SJ, Zhai LP, Yang XY, Wang ZH, Wu ZT, Han Y.
    J Dig Dis; 2012 Mar; 13(3):143-152. PubMed ID: 22356309
    [Abstract] [Full Text] [Related]

  • 2. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.
    Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T, Fan D.
    Int J Cancer; 2005 Jan 10; 113(2):213-20. PubMed ID: 15386405
    [Abstract] [Full Text] [Related]

  • 3. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.
    Du J, Shi Y, Pan Y, Jin X, Liu C, Liu N, Han Q, Lu Y, Qiao T, Fan D.
    Cancer Biol Ther; 2005 Feb 10; 4(2):242-7. PubMed ID: 15846068
    [Abstract] [Full Text] [Related]

  • 4. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY, Sciandra J, Siemann DW.
    Biochem Pharmacol; 1989 Nov 01; 38(21):3697-705. PubMed ID: 2574574
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH, Wang XT, Yang J, Lian C, Kong FB, Wei WY, Luo W, Xiao Q, Xie YB.
    World J Gastroenterol; 2013 Jul 14; 19(26):4155-65. PubMed ID: 23864778
    [Abstract] [Full Text] [Related]

  • 6. Function of PrPC (1-OPRD) in biological activities of gastric cancer cell lines.
    Liang J, Wang J, Luo G, Pan Y, Wang X, Guo C, Zhang D, Yin F, Zhang X, Liu J, Wang J, Guo X, Wu K, Fan D.
    J Cell Mol Med; 2009 Jul 14; 13(11-12):4453-64. PubMed ID: 19210573
    [Abstract] [Full Text] [Related]

  • 7. Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance.
    Wang JH, Du JP, Zhang YH, Zhao XJ, Fan RY, Wang ZH, Wu ZT, Han Y.
    World J Gastroenterol; 2011 Sep 21; 17(35):3986-93. PubMed ID: 22046086
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH, Wei WY, Cao WL, Zhang XS, Xie YB, Xiao Q.
    BMC Cancer; 2014 Dec 03; 14():904. PubMed ID: 25466554
    [Abstract] [Full Text] [Related]

  • 9. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
    Zhu FS, Chen XM, Huang ZG, Wang ZR, Zhang DW, Zhang X.
    J Dig Dis; 2010 Feb 03; 11(1):34-42. PubMed ID: 20132429
    [Abstract] [Full Text] [Related]

  • 10. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype.
    Schisselbauer JC, Crescimanno M, D'Alessandro N, Clapper M, Toulmond S, Tapiero H, Tew KD.
    Cancer Commun; 1989 Feb 03; 1(2):133-9. PubMed ID: 2639724
    [Abstract] [Full Text] [Related]

  • 11. Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32.
    Hong L, Wang J, Han Y, Zhao Y, Gao J, Wang J, Han Y, Zhang X, Yan L, Zhou X, Qiao T, Chen Z, Fan D.
    Cell Biol Int; 2007 Sep 03; 31(9):1010-5. PubMed ID: 17470401
    [Abstract] [Full Text] [Related]

  • 12. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH, Wang XT, Yang J, Kong FB, Lian C, Wei WY, Luo W, Xie YB, Xiao Q.
    J Cell Biochem; 2014 Jan 03; 115(1):34-41. PubMed ID: 24038122
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein.
    Liang J, Luo G, Ning X, Shi Y, Zhai H, Sun S, Jin H, Liu Z, Zhang F, Lu Y, Zhao Y, Chen X, Zhang H, Guo X, Wu K, Fan D.
    Biochem Cell Biol; 2007 Jun 03; 85(3):375-83. PubMed ID: 17612632
    [Abstract] [Full Text] [Related]

  • 15. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F, Hamaï A, Gao P, Jalil A, Cahuzac N, Chouaib S, Mehrpour M.
    Cancer Res; 2007 Nov 15; 67(22):10910-9. PubMed ID: 18006836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
    Gaudiano G, Koch TH, Lo Bello M, Nuccetelli M, Ravagnan G, Serafino A, Sinibaldi-Vallebona P.
    Biochem Pharmacol; 2000 Dec 15; 60(12):1915-23. PubMed ID: 11108808
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
    Kim R, Ohi Y, Inoue H, Aogi K, Toge T.
    Anticancer Res; 1999 Dec 15; 19(3A):1779-83. PubMed ID: 10470115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.